Personal information

Other IDs

Scopus Author ID: 55835590300

Keywords

Immunology, immunotherapy, gene therapy, cancer, molecular biology

Countries

Spain

Activities

Collapse all

Employment (1)

Universidad Europea de Madrid: Madrid, Madrid, ES

2013-09-13 to present | TERNURED PROFESSOR (FARMACIA, BIOTECNOLOGÍA, ÓPTICA Y NUTRICIÓN)
Employment
Source: Self-asserted source
Esther San José

Education and qualifications (4)

Universidad Autónoma de Madrid: Madrid, Madrid, ES

1997-12-01 to 2009-04-30 | DOCTOR (MOLECULAR BIOLOGY AND BIOCHEMISTRY)
Qualification
Source: Self-asserted source
Esther San José

Universidad Autonoma de Madrid Centro de Biología Molecular Severo Ochoa: Madrid, Madrid, ES

1994-01-17 to 1997-11-30 | PhD STUDENT (MOLECULAR BIOLOGY AND BIOCHEMISTRY)
Education
Source: Self-asserted source
Esther San José

Instituto de Salud Carlos III Campus de Majadahonda: Majadahonda, Madrid, ES

1991-05-01 to 1993-12-31 | PhD STUDENT (MICROBIOLOGY, VIROLOGY, AND IMMUNOLOGY RESEARCH CENTER)
Education
Source: Self-asserted source
Esther San José

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

1984-09-01 to 1990-06-19 | BACHELOR (CHEMISTRY, BIOCHEMISTRY)
Education
Source: Self-asserted source
Esther San José

Works (18)

COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults

Journal of Clinical Medicine
2023-01-06 | Journal article
DOI: 10.3390/jcm12020488
Contributors: José Rivera-Torres; Natalia Girón; Esther San José
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

IMPLEMENTATION OF VIRTUAL SIMULATION PLATFORMS IN COVID TIMES: PERCEPTION QUANTITATIVE ANALYSIS

2021-07 | Conference paper
DOI: 10.21125/edulearn.2021.2167
Contributors: Esther San José Martínez; Beatriz Sáez Pizarro; Gonzalo Mariscal Vivas; Cristina Andreu Vázquez
Source: check_circle
Crossref

Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission

Journal of Clinical Medicine
2020-12-25 | Journal article
DOI: 10.3390/jcm10010042
Part of ISSN: 2077-0383
Source: Self-asserted source
Esther San José
grade
Preferred source (of 3)‎

Identification of a tumor-specific allo-HLA–restricted γδTCR

Blood Advances
2019-10-08 | Journal article
DOI: 10.1182/bloodadvances.2019032409
Part of ISSN: 2473-9529
Part of ISSN: 2473-9537
Source: Self-asserted source
Esther San José

Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential

Frontiers in Pharmacology
2019-09-18 | Journal article
DOI: 10.3389/fphar.2019.01011
Part of ISSN: 1663-9812
Source: Self-asserted source
Esther San José

IMPLEMENTATION OF INQUIRY BASED LEARNING DURING THE FIRST TWO YEARS IN BIOTECHNOLOGY DEGREE

ICERI2018 Proceedings
2018-11 | Journal article
DOI: 10.21125/iceri.2018.1468
Source: Self-asserted source
Esther San José

Cancer and immune response

Basis of cancer immunotherapy
2018-06-10 | Book chapter
Part of ISBN: 978-84-941494-6-7
Source: Self-asserted source
Esther San José

Expression of a modified form of CD4 results in the release of an anti-HIV factor derived from the Env sequence

Journal of Immunology
2009 | Journal article
DOI: 10.4049/jimmunol.0802944
Source: Self-asserted source
Esther San José

Human TCR that incorporate CD3ζ induce highly preferred pairing between TCRα and β chains following gene transfer

Journal of Immunology
2008 | Journal article
Source: Self-asserted source
Esther San José

Targeting the wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells

Journal of Immunology
2007 | Journal article
DOI: 10.4049/jimmunol.179.9.5803
Source: Self-asserted source
Esther San José
grade
Preferred source (of 2)‎

All or none downregulation of the T cell antigen receptor

Inmunología
2001-07 | Journal article
Source: Self-asserted source
Esther San José

Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism

Immunity
2000 | Journal article
Source: Self-asserted source
Esther San José

Conformational and biochemical differences in the TCR · CD3 complex of CD8+versus CD4+mature lymphocytes revealed in the absence of CD3γ

Journal of Biological Chemistry
1999 | Journal article
DOI: 10.1074/jbc.274.49.35119
Source: Self-asserted source
Esther San José

Receptor engagement transiently diverts the T cell receptor heterodimer from a constitutive degradation pathway

Journal of Biological Chemistry
1999 | Journal article
DOI: 10.1074/jbc.274.47.33740
Source: Self-asserted source
Esther San José

Assembly of the TCR/CD3 complex: CD3ε/δ and CD3ε/γ dimers associate indistinctly with both TCRα and TCRβ chains. Evidence for a double TCR heterodimer model

European Journal of Immunology
1998 | Journal article
DOI: 10.1002/(SICI)1521-4141(199801)28:01<12::AID-IMMU12>3.0.CO;2-9
Source: Self-asserted source
Esther San José

Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication

Human gene therapy
1998 | Journal article
DOI: 10.1089/hum.1998.9.9-1345
Source: Self-asserted source
Esther San José

Differential cytosolic tail dependence and intracellular fate of T-cell receptors internalized upon activation with superantigen or phorbol ester

Research in Immunology
1997 | Journal article
DOI: 10.1016/S0923-2494(97)80865-6
Source: Self-asserted source
Esther San José

Megalomicin inhibits HIV-1 replication and interferes with gp160 processing

Virology
1997 | Journal article
DOI: 10.1006/viro.1997.8872
Source: Self-asserted source
Esther San José
How many people are using ORCID?